KH
Keisuke Hanada
stat.MEstat.APMeta-Analysis as TopicPancreatic NeoplasmsPostoperative ComplicationsRestricted mean survival timeAntineoplastic Combined Chemotherapy ProtocolsBartlett correctionBiometryCarcinoma, Pancreatic Ductal
On Valency
published · living versionsW_b5zg4qjc·v1 · currentpublished
Preprints & journals
15 papers in the corpus · 2022–2026Functional meta-analysis of survival curves across reporting formats and time points2610.27601v1 · Keisuke Hanada2026 · 0 citationsarXivon Valency
Integrating Meta-Analysis Into a Specific Study (InMASS) for Estimating the Target-Population Average Treatment Effect.42703888 · Hanada, Keisuke, Kojima, Masahiro2026 · 0 citationsBiometrical journal. Biometrische Zeitschrift. 2026;68(5):e70169
EUS Shear Wave Elastography for Assessing Pancreatic Fibrosis: An Exploratory Study of Its Histological Correlation.42833997 · Nakahata, Akiya, Yamashita, Yasunobu, Kojima, Fumiyoshi et al.2026 · 0 citationsDigestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society. 2026;38(10):e70308
Hill Classification Predicts Postoperative Pneumonia After Minimally Invasive Distal Gastrectomy for Gastric Cancer.42723290 · Nagano, Shotaro, Kitadani, Junya, Hayata, Keiji et al.2026 · 0 citationsWorld journal of surgery. 2026;50(10):3032-3036
Correction: Potential surrogate endpoint for B-cell hematologic malignancy: A systematic review and meta-analysis.42533026 · Hirano, Satoshi, Hanada, Keisuke, Maeda, Hideki2026 · 0 citationsScientific reports. 2026;16(1)
Impact of Stent Type on Surgical Outcomes in Pancreatic Cancer Patients Undergoing Preoperative Biliary Drainage.42433174 · Tamura, Takashi, Matsumori, Tomoaki, Nishikawa, Yoshihiro et al.2026 · 0 citationsDigestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society. 2026;38(7):e70229
Random-effects meta-analysis via generalized linear mixed models: A Bartlett-corrected approach for few studies.42613049 · Hanada, Keisuke, Sugimoto, Tomoyuki2026 · 0 citationsBiometrics. 2026;82(3)
Comparison of Nanoliposomal Irinotecan Plus Fluorouracil/Leucovorin and S-1, Irinotecan, and Oxaliplatin as Second-Line Chemotherapy After Gemcitabine Plus Nab-Paclitaxel for Unresectable Pancreatic Cancer.42052986 · Itonaga, Masahiro, Ashida, Reiko, Tamura, Takashi et al.2026 · 0 citationsJournal of hepato-biliary-pancreatic sciences. 2026;33(9):701-711
Random effect restricted mean survival time model.41987523 · Hanada, Keisuke, Kojima, Masahiro2026 · 0 citationsJournal of biopharmaceutical statistics. 2026:1-16
A Clustering Approach for Basket Trials Based on Treatment Response Trajectories2511.09890v3 · Masahiro Kojima, Keisuke Hanada, Atsuya Sato2025 · 0 citationsarXiv
Adjusting confidence intervals under covariate-adaptive randomization in non-inferiority and equivalence trials.41047116 · Kojima, Masahiro, Mano, Hirotaka, Yamada, Kana et al.2025 · 0 citationsContemporary clinical trials. 2025;158:108099
Potential surrogate endpoint for B-cell hematologic malignancy: A systematic review and meta-analysis.40456850 · Hirano, Satoshi, Hanada, Keisuke, Maeda, Hideki2025 · 0 citationsScientific reports. 2025;15(1):19300
Moment-based Random-effects Meta-analysis Equipped with Huber's M-Estimation2407.04446v2 · Keisuke Hanada, Tomoyuki Sugimoto2024 · 0 citationsarXiv
Bayesian Parametric Methods for Deriving Distribution of Restricted Mean Survival Time2406.06071v2 · Keisuke Hanada, Masahiro Kojima2024 · 0 citationsarXiv
Comparison of baseline covariate adjustment methods for restricted mean survival time.38228232 · Hanada, Keisuke, Moriya, Junji, Kojima, Masahiro2024 · 2 citationsContemporary clinical trials. 2024;138:107440
Career total: 22 works. 15 are in this corpus.
Profile built from the corpus for this byline.
Author records are still filling in while the Hub is in alpha. If this is your page, you'll be able to claim it soon. Spot a mistake? Tell us.